论文部分内容阅读
目的探究盐酸氨溴索在慢性支气管炎患者中的应用价值。方法选取我院在2011年8月～2013年4月收治的采用盐酸氨溴索进行治疗的61例慢性支气管炎患者的临床资料,并与同期采用常规治疗的59例患者进行对比,观察其临床治疗效果。结果治疗组患者总有效率为95.08%;对照组患者总有效率为76.27%,治疗组治疗效果优于对照组,具有差异性,有统计学意义(P<0.05)。结论在常规对症治疗的基础上给予慢性支气管炎患者盐酸氨溴索治疗,可有效改善其临床症状,值得推广应用。
Objective To investigate the value of ambroxol hydrochloride in patients with chronic bronchitis. Methods The clinical data of 61 patients with chronic bronchitis treated with Ambroxol Hydrochloride in our hospital from August 2011 to April 2013 were selected and compared with 59 patients treated routinely in the same period. treatment effect. Results The total effective rate in the treatment group was 95.08%. The total effective rate in the control group was 76.27%. The treatment effect in the treatment group was superior to that in the control group, with statistical significance (P <0.05). Conclusion Ambroxol hydrochloride is given to patients with chronic bronchitis on the basis of conventional symptomatic treatment, which can effectively improve the clinical symptoms and is worth popularizing and applying.